Parallel Session Angiogenesis inhibitor 2025.07.03 Bouthaina S. Dabaja on Bridging Strategies: Can Radiation Therapy Be Considered a ‘Novel Agent’? 2025.07.02 Prof. Ali Bazarbachi on Progress in Transplant Outcomes for Relapsed HL 2025.07.02 Prof. Martin Dreyling on Science, Diversity, and the Vision Behind EHA2025 2025.07.02 Prof. Evangelos Terpos on Key Biomarkers in the EHA–EMN Guidelines for Multiple Myeloma 2025.07.02 Deciphering Precision Immunotherapy for Gastric Cancer: Insights from Evolving Guidelines 2025.07.02 Immunotherapy for Locally Advanced Gastric Cancer: Current Landscape and Future Directions 2025.07.02 Human Proteome Navigation Initiative 2025.07.01 «previous next»
